Tech Company Financing Transactions

RayzeBio Funding Round

RayzeBio, based in San Diego, scored $45 million in funding from venBio, Versant Ventures and Samsara BioCapital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

9880 Campus Point Dr. 410
San Diego, CA 92121
USA

Phone

Undisclosed

Website

www.rayzebio.com

Email Address

[email protected]

Overview

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ken Song

        

Chief Technical Officer

Deborah Charych

        

Vice President

Derek Cole

        

Vice President

Gary Li

        

Vice President

Nicholas Smith

        

VP - Finance

Kathie Huynh

        

VP - Operations

Eric Bischoff

        

Browse more venture capital transactions:

Prev: 10/15/2020: Fiveable venture capital transaction
Next: 10/15/2020: Osmind venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary